Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Abdel-Moneim Osman
    Professor
    Department of Medicine
    King Abdel-Aziz University
    Saudi Arabia
    moneimosman@hotmail.com
    GJCT
    Research Interest: Cancer Research.Pharmacology, Cell Cycle Effect, Drug-Drug Intertaction, Chemoprotection, Potentiation olf Cytotoxic Drugs
    More Info.
    Hua Yang
    Department of Cell Biology
    Peking University,
    China
    yanghua@bjmu.edu.cn
    GJCT

    Research Interest: Oncology,including basic and clinical


    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Esteban Orenes-Pinero
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia
    Spain
    eorenes@um.es
    GJCT

    Research Interest: Current Professional Activity: Fibrilación Auricular, Miocardiopatía Hipertrófica, Micrornas,Remodelado Cardíaco


    More Info.
    Jose Maria Pereira de Godoy
    Assistant Professor
    Regional Medical School
    egional Medical School, São José do Rio Preto
    Brazil
    godoyjmp@riopreto.com.br
    GJCT
    Research Interest: Breast CancerRehabilitationLymphedema  
    More Info.
    Athanasios Papatsoris
    Urology
    Royal London Hospital
    UK
    agpapatsoris@yahoo.gr
    GJCT


    Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.

    More Info.
    Vijai Kant Agnihotri
    Scientist
    Institute of Himalayan Bioresource Technology
    India
    kantvijai@yahoo.com
    GJCT

    Research Interest: Natural Product Chemistry, Toxicology, Spectroscopy, Essential Oils

    More Info.
    Yatendra Kumar Satija
    Yatendra Kumar Satija Molecular Oncology Lab
    National Institute of Immunology
    USA
    yksatija@gmail.com
    GJCT

    Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

    More Info.
    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna
    Italy
    letizia.polito@unibo.it
    GJCT

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    View more
    mendeley

    Assessment of the role of multimodality imaging for treatment volume definition of intracranial ependymal tumors: An original article

    DOI Logo 10.17352/2581-5407.000041

    Published On: July 06, 2021 | Pages: 043 - 045

    Author(s): Ferrat Dincoglan, Omer Sager*, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View
    mendeley

    Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

    DOI Logo 10.17352/2581-5407.000040

    Published On: May 19, 2021 | Pages: 035 - 042

    Author(s): Benjamin A Babalola*, Gboyega E Adebami and Samuel E Akinsuyi
    Abstract View Full Article View
    mendeley

    Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)

    DOI Logo 10.17352/2581-5407.000039

    Published On: March 15, 2021 | Pages: 031 - 034

    Author(s): Omer Sager*, Ferrat Dincoglan, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View
    mendeley

    Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment

    DOI Logo 10.17352/2581-5407.000038

    Published On: February 24, 2021 | Pages: 016 - 030

    Author(s): ISh Nadiradze* and NSh Chigogidze
    Abstract View Full Article View
    mendeley

    Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma

    DOI Logo 10.17352/2581-5407.000037

    Published On: February 13, 2021 | Pages: 010 - 015

    Author(s): Amany R Keruakous*, Silas Day and Carrie Yuen
    Abstract View Full Article View
    mendeley

    Application of nano based drug delivery channel against leukemia chemotherapeutic resistance

    DOI Logo 10.17352/2581-5407.000036

    Published On: February 09, 2021 | Pages: 001 - 009

    Author(s): Rahul Bhattacharjee*, Olabimtan Olabode H, Ochigbo Victor and Samuel Florence
    Abstract View Full Article View
    mendeley

    Atypical Fibroadenoma Presentation of a Case

    DOI Logo 10.17352/2581-5407.000035

    Published On: November 10, 2020 | Pages: 042 - 044

    Author(s): Juana Teresa Santiago Pérez*, José Miguel González Barcena, Yuranis Gárciga Martin and Yahumara Suarez Morales
    Abstract View Full Article View
    mendeley

    Brain Tumor: An overview of the basic clinical manifestations and treatment

    DOI Logo 10.17352/2581-5407.000034

    Published On: October 20, 2020 | Pages: 038 - 041

    Author(s): Abolanle AA Kayode*, Amina Shahzadi, Muhammad Akram, Hina Anwar, Omowumi T Kayode, Omowumi O Akinnawo and Sunday O Okoh
    Abstract View Full Article View
    mendeley

    Influence of Intra-ductal Carcinoma on Clinical Outcomes in Men with Prostate Cancer: Systematic Review and Meta-analysis

    DOI Logo 10.17352/2581-5407.000033

    Published On: October 17, 2020 | Pages: 032 - 037

    Author(s): Jatinder Kumar*, Muhammad Umar Alam, Karthik Tanneru, Shiva Gautam, Daniel Norez, Charu Shastri, Joseph Costa, Mark Bandyk, Hariharan Palayapalayam Ganapathi, Shahriar Koochekpour, Sanjeev Shukla and KC Balaji
    Abstract View Full Article View
    mendeley

    Nav channels in cancers: Non-classical roles

    DOI Logo 10.17352/2581-5407.000032

    Published On: October 15, 2020 | Pages: 028 - 032

    Author(s): Hengrui Liu*
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT